Effects of Vaginal Lactoferrin Administration Prior to Genetic Amniocentesis on Inflammatory Mediators

NCT02695563 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Pregnancy

Interventions

DRUG: Lactoferrin

Sponsor

Università degli Studi di Ferrara